These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 16230381)

  • 1. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development.
    Boerboom D; Paquet M; Hsieh M; Liu J; Jamin SP; Behringer RR; Sirois J; Taketo MM; Richards JS
    Cancer Res; 2005 Oct; 65(20):9206-15. PubMed ID: 16230381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
    Boerboom D; White LD; Dalle S; Courty J; Richards JS
    Cancer Res; 2006 Feb; 66(4):1964-73. PubMed ID: 16488995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression.
    Laguë MN; Paquet M; Fan HY; Kaartinen MJ; Chu S; Jamin SP; Behringer RR; Fuller PJ; Mitchell A; Doré M; Huneault LM; Richards JS; Boerboom D
    Carcinogenesis; 2008 Nov; 29(11):2062-72. PubMed ID: 18687666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT signaling in ovarian follicle biology and tumorigenesis.
    Boyer A; Goff AK; Boerboom D
    Trends Endocrinol Metab; 2010 Jan; 21(1):25-32. PubMed ID: 19875303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma.
    Ohishi Y; Oda Y; Kurihara S; Kaku T; Kobayashi H; Wake N; Tsuneyoshi M
    Histopathology; 2011 Feb; 58(3):423-32. PubMed ID: 21299609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of anti-Müllerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries.
    Ball BA; Conley AJ; MacLaughlin DT; Grundy SA; Sabeur K; Liu IK
    Theriogenology; 2008 Oct; 70(6):968-77. PubMed ID: 18599114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seminiferous tubule degeneration and infertility in mice with sustained activation of WNT/CTNNB1 signaling in sertoli cells.
    Boyer A; Hermo L; Paquet M; Robaire B; Boerboom D
    Biol Reprod; 2008 Sep; 79(3):475-85. PubMed ID: 18480464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
    Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
    Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation.
    Martinez G; Wijesinghe M; Turner K; Abud HE; Taketo MM; Noda T; Robinson ML; de Iongh RU
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4794-806. PubMed ID: 19515997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
    Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
    Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic hair follicle fate change by augmented beta-catenin through Shh and Bmp signaling.
    Suzuki K; Yamaguchi Y; Villacorte M; Mihara K; Akiyama M; Shimizu H; Taketo MM; Nakagata N; Tsukiyama T; Yamaguchi TP; Birchmeier W; Kato S; Yamada G
    Development; 2009 Feb; 136(3):367-72. PubMed ID: 19141668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
    Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM
    Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Wnt/beta-catenin signaling in distinct histologic subtypes of human germ cell tumors.
    Fritsch MK; Schneider DT; Schuster AE; Murdoch FE; Perlman EJ
    Pediatr Dev Pathol; 2006; 9(2):115-31. PubMed ID: 16822086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.
    Yang W; Yan HX; Chen L; Liu Q; He YQ; Yu LX; Zhang SH; Huang DD; Tang L; Kong XN; Chen C; Liu SQ; Wu MC; Wang HY
    Cancer Res; 2008 Jun; 68(11):4287-95. PubMed ID: 18519688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.
    Yin YJ; Katz V; Salah Z; Maoz M; Cohen I; Uziely B; Turm H; Grisaru-Granovsky S; Suzuki H; Bar-Shavit R
    Cancer Res; 2006 May; 66(10):5224-33. PubMed ID: 16707447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer.
    Badiglian Filho L; Oshima CT; De Oliveira Lima F; De Oliveira Costa H; De Sousa Damião R; Gomes TS; Gonçalves WJ
    Oncol Rep; 2009 Feb; 21(2):313-20. PubMed ID: 19148501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies.
    Groen RW; Oud ME; Schilder-Tol EJ; Overdijk MB; ten Berge D; Nusse R; Spaargaren M; Pals ST
    Cancer Res; 2008 Sep; 68(17):6969-77. PubMed ID: 18757411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
    Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
    Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.